104 Participants Needed

ABBV-932 for Healthy Subjects

Recruiting at 1 trial location
AC
Overseen ByABBVIE CALL CENTER
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: AbbVie

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new drug called ABBV-932 in healthy adults to see how it moves through the body and if it is safe.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.

Who Is on the Research Team?

AI

ABBVIE INC.

Principal Investigator

AbbVie

Are You a Good Fit for This Trial?

This trial is for healthy adults, including Japanese and Han Chinese individuals with a BMI between 18.0 to 32.0 kg/m2. Participants must be in good health based on medical history, physical exams, lab tests, neurological exams, and ECG results. Those who've had significant illness or surgery within the last 30 days cannot join.

Inclusion Criteria

I am a healthy individual of Japanese or Han Chinese descent with a BMI between 18.0 and 30.0.
My overall health is good based on recent medical exams.
I am healthy with a BMI between 18.0 and 32.0.

Exclusion Criteria

I haven't had any serious illnesses, infections, fevers, hospital stays, or surgeries in the last 30 days.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive ABBV-932 or placebo on Day 1 and are followed for pharmacokinetics, safety, and tolerability assessment

30 days

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • ABBV-932
  • Placebo
Trial Overview The study is testing ABBV-932 oral capsules to see how they're processed by the body (pharmacokinetics) and to check their safety and tolerability compared to a placebo (a pill without active medication).
How Is the Trial Designed?
7Treatment groups
Experimental Treatment
Placebo Group
Group I: Part 3: Japanese Participants: ABBV-932Experimental Treatment1 Intervention
Group II: Part 3: Han-Chinese Participants: ABBV-932Experimental Treatment1 Intervention
Group III: Part 2: Sequence 2Experimental Treatment1 Intervention
Group IV: Part 2: Sequence 1Experimental Treatment1 Intervention
Group V: Part 1: ABBV-932Experimental Treatment1 Intervention
Group VI: Part 3: Japanese Participants: PlaceboPlacebo Group1 Intervention
Group VII: Part 1: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

AbbVie

Lead Sponsor

Trials
1,079
Recruited
535,000+
Founded
2013
Headquarters
North Chicago, USA
Known For
Immunology treatments
Top Products
Humira (adalimumab), Skyrizi (risankizumab), Rinvoq (upadacitinib)

Dr. Roopal Thakkar

AbbVie

Chief Medical Officer since 2023

MD from Wayne State University School of Medicine

Robert A. Michael profile image

Robert A. Michael

AbbVie

Chief Executive Officer

Bachelor's degree in Finance from the University of Illinois

Gedeon Richter Plc.

Industry Sponsor

Trials
17
Recruited
173,000+
Founded
1901
Headquarters
Budapest, Hungary
Known For
Women's Health Innovations
Top Products
Reagila (cariprazine), Pegfilgrastim (biosimilar), Estelle (contraceptive)
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security